Remdesivir and the Liver: A Concise Narrative Review of Remdesivir-Associated Hepatotoxicity in Patients Hospitalized Due to COVID-19
Severe acute respiratory syndrome coronavirus 2 has infected millions of people, but about 20% of infected individuals do not develop symptoms. COVID-19 is an inflammatory disease that affects a portion of individuals infected with the virus and it is associated with liver injury and other complicat...
Saved in:
Main Authors: | Alireza FakhriRavari (Author), Mazyar Malakouti (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Renal and liver injury following the treatment of COVID-19 by remdesivir
by: Mohsen Mohammad Rahimi, et al.
Published: (2021) -
The journey of remdesivir: from Ebola to COVID-19
by: Joe Pardo, et al.
Published: (2020) -
Safety of Remdesivir and Tocilizumab in COVID-19 Treatment
by: Alexandra A. Taube, et al.
Published: (2020) -
Remdesivir-Bringing Hope for COVID-19 Treatment
by: Naser F. Al-Tannak, et al.
Published: (2020) -
The use of Remdesivir in pregnant women with COVID-19
by: Gulbanu Shaimerdenova, et al.
Published: (2023)